| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |